Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1950 of 2873 entries
View as:

Objective Assessment of Technical Skills in Cardiothoracic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01433029 Org: User:
Start: 09/01/11 End: 01/22/17 Due: 01/22/18

Prospective Measurement of Post-Treatment Lymphedema

Phase: N/A Priority: Normal
NCT ID: NCT00495950 Org: User:
Start: 05/31/06 End: 11/30/16 Due: 11/30/17

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02402920 Org: User:
Start: 07/22/15 End: 07/31/25 Due: 07/31/26

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

Phase: N/A Priority: Normal
NCT ID: NCT04066894 Org: User:
Start: 04/12/19 End: 09/01/22 Due: 09/01/23

Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01630564 Org: User:
Start: 03/11/13 End: 05/30/18 Due: 05/30/19

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03203525 Org: User:
Start: 06/23/20 End: 12/31/26 Due: 12/31/27

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

Phase: N/A Priority: Normal
NCT ID: NCT05136807 Org: User:
Start: 06/07/16 End: 02/02/27 Due: 02/02/28

A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT06191978 Org: User:
Start: 03/07/24 End: 12/31/28 Due: 12/31/29

Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter

Phase: N/A Priority: Normal
NCT ID: NCT01900730 Org: User:
Start: 07/31/14 End: 06/01/18 Due: 06/01/19

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

Phase: N/A Priority: Normal
NCT ID: NCT00038675 Org: User:
Start: 06/30/01 End: 11/30/13 Due: 11/30/14

BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01248247 Org: User:
Start: 06/02/11 End: 11/30/20 Due: 11/30/21

RTA 744 Injection in Patients With Leptomeningeal Disease

Phase: N/A Priority: Normal
NCT ID: NCT00512460 Org: User:
Start: 09/30/06 End: 03/31/10 Due: 03/31/11

Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

Phase: N/A Priority: Normal
NCT ID: NCT00500578 Org: User:
Start: 02/28/03 End: 01/31/09 Due: 01/31/10

A Survey of Parent/Caregiver Practices on the Storage, Use, and Disposal of Opioids in a Comprehensive Cancer Center

Phase: N/A Priority: Normal
NCT ID: NCT03390283 Org: User:
Start: 12/20/17 End: 11/17/23 Due: 11/17/24

Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT05436327 Org: User:
Start: 05/06/22 End: 06/30/25 Due: 06/30/26

Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00527657 Org: User:
Start: 02/09/06 End: 02/02/12 Due: 02/02/13

Oral Supplementation to Enhance Recovery Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT03204266 Org: User:
Start: 08/16/17 End: 05/25/22 Due: 05/25/23

Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT02010645 Org: User:
Start: 03/31/14 End: 01/02/19 Due: 01/02/20

Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver

Phase: N/A Priority: Normal
NCT ID: NCT00766220 Org: User:
Start: 10/31/09 End: 01/31/12 Due: 01/31/13

Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00338728 Org: User:
Start: 10/03/03 End: 11/27/18 Due: 11/27/19

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01582152 Org: User:
Start: 07/31/12 End: 03/31/16 Due: 03/31/17

Alemtuzumab and Pentostatin In T-cell Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT00453193 Org: User:
Start: 09/30/04 End: 03/31/10 Due: 03/31/11

Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00857389 Org: User:
Start: 03/02/09 End: 03/09/19 Due: 03/09/20

Diagnostic Aids for Detection and Diagnosis of Oral Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02251639 Org: User:
Start: 10/31/14 End: 10/31/20 Due: 10/31/21

Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease

Phase: N/A Priority: Normal
NCT ID: NCT00632359 Org: User:
Start: 02/29/08 End: 10/31/15 Due: 10/31/16